ATE155792T1 - Ungesatigte 17-beta-substituierte-3-carboxy steroide - Google Patents

Ungesatigte 17-beta-substituierte-3-carboxy steroide

Info

Publication number
ATE155792T1
ATE155792T1 AT92910992T AT92910992T ATE155792T1 AT E155792 T1 ATE155792 T1 AT E155792T1 AT 92910992 T AT92910992 T AT 92910992T AT 92910992 T AT92910992 T AT 92910992T AT E155792 T1 ATE155792 T1 AT E155792T1
Authority
AT
Austria
Prior art keywords
group
chem
hydrogen
alkyl group
cycloalkyl
Prior art date
Application number
AT92910992T
Other languages
English (en)
Inventor
Achille Panzeri
Marcella Nesi
Salle Enrico Di
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Application granted granted Critical
Publication of ATE155792T1 publication Critical patent/ATE155792T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Details Of Garments (AREA)
  • Ceramic Products (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Plant Substances (AREA)
AT92910992T 1991-05-24 1992-05-22 Ungesatigte 17-beta-substituierte-3-carboxy steroide ATE155792T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi

Publications (1)

Publication Number Publication Date
ATE155792T1 true ATE155792T1 (de) 1997-08-15

Family

ID=11359980

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92910992T ATE155792T1 (de) 1991-05-24 1992-05-22 Ungesatigte 17-beta-substituierte-3-carboxy steroide

Country Status (26)

Country Link
US (1) US5212166A (de)
EP (2) EP0517047A1 (de)
JP (1) JP3226919B2 (de)
CN (1) CN1035055C (de)
AT (1) ATE155792T1 (de)
AU (1) AU655280B2 (de)
CA (1) CA2087953A1 (de)
CZ (1) CZ281309B6 (de)
DE (1) DE69221074T2 (de)
DK (1) DK0540717T3 (de)
ES (1) ES2106185T3 (de)
FI (1) FI930277A (de)
HU (1) HUT64083A (de)
ID (1) ID954B (de)
IE (1) IE921634A1 (de)
IL (1) IL101947A (de)
IT (1) IT1259419B (de)
MX (1) MX9202438A (de)
MY (1) MY131089A (de)
NO (1) NO930244L (de)
NZ (1) NZ242850A (de)
RU (1) RU2104283C1 (de)
TW (1) TW213467B (de)
WO (1) WO1992020700A1 (de)
YU (1) YU52992A (de)
ZA (1) ZA923758B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK129294A3 (en) * 1992-04-30 1995-07-11 Smithkline Beecham Corp 17-alpha and 17-beta-substituted estra-1,3,5(10)-triene-3- -carboxylic acid
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
ES2185666T3 (es) * 1993-09-03 2003-05-01 Smithkline Beecham Corp Formulacion estabilizada para comprimidos.
GB9324371D0 (en) * 1993-11-26 1994-01-12 Erba Carlo Spa Side chain fluoro substituted 3-carboxysteroids
US5430157A (en) * 1993-12-13 1995-07-04 Eli Lilly And Company Reduced phenanthrenes
GB9402041D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Corp Compounds
US5714480A (en) * 1994-03-31 1998-02-03 Smithkline Beecham Corporation Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
WO1995028413A1 (en) * 1994-04-15 1995-10-26 Smithkline Beecham Corporation 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
EP3827747A1 (de) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharmainformatiksystem
EP1945240B1 (de) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Zusammensetzungen mit rezeptor-assoziierten protein (rap) varianten, die für cr-haltige proteine spezifisch sind und ihre verwendungen
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5041433A (en) * 1987-04-29 1991-08-20 Smithkline Beecham Corporation 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
EP0725074A3 (de) * 1992-04-20 1996-11-20 Sankyo Co Verbindungen zur Verwendung also Zwischenprodukte zur Herstellung von Androst-3,5-dien-3-carboxy-Derivaten

Also Published As

Publication number Publication date
NO930244D0 (no) 1993-01-25
IE921634A1 (en) 1992-12-02
MY131089A (en) 2007-07-31
AU1778192A (en) 1992-12-30
DE69221074D1 (de) 1997-09-04
JPH06500342A (ja) 1994-01-13
US5212166A (en) 1993-05-18
CZ26593A3 (en) 1993-11-17
EP0540717B1 (de) 1997-07-23
FI930277A0 (fi) 1993-01-22
WO1992020700A1 (en) 1992-11-26
DE69221074T2 (de) 1997-11-13
MX9202438A (es) 1992-11-01
IL101947A (en) 1996-01-19
ES2106185T3 (es) 1997-11-01
YU52992A (sh) 1995-03-27
NO930244L (no) 1993-01-27
ITMI911432A0 (it) 1991-05-24
CA2087953A1 (en) 1992-11-25
HU9300176D0 (en) 1993-04-28
ID954B (id) 1996-09-25
HUT64083A (en) 1993-11-29
AU655280B2 (en) 1994-12-15
CN1035055C (zh) 1997-06-04
ZA923758B (en) 1993-01-27
NZ242850A (en) 1994-01-26
ITMI911432A1 (it) 1992-11-24
RU2104283C1 (ru) 1998-02-10
CN1067057A (zh) 1992-12-16
EP0517047A1 (de) 1992-12-09
FI930277A (fi) 1993-01-22
DK0540717T3 (da) 1997-08-18
TW213467B (de) 1993-09-21
EP0540717A1 (de) 1993-05-12
JP3226919B2 (ja) 2001-11-12
CZ281309B6 (cs) 1996-08-14
IT1259419B (it) 1996-03-18

Similar Documents

Publication Publication Date Title
DE69221074D1 (de) Ungesatigte 17-beta-substituierte-3-carboxy steroide
HUP0302468A2 (hu) Alfa V integrin receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
HUP0004477A2 (hu) Herbicid hatású 3-(1,2-benzizotiazol- vagy-izoxazol-5-il)-csoporttal helyettesített pirimidinszármazékok, intermedierjeik, előállításuk és alkalmazásuk
MY101849A (en) Improvements in or relating to cyanopyrazole herbicides.
CO4910142A1 (es) Compuestos de furano nitrona
ES2053764T3 (es) Agentes antiparasitarios.
HUT75647A (en) Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia
DE69522118T2 (de) Thiazolidonon- oder oxazolidinonderivate zur behandlung von angina pectoris und zusammensetzungen die diese als wirkstoffe enthält
HUP0101996A2 (hu) Szinergetikus fungicid hatóanyag keverék és alkalmazása
ES2174077T3 (es) Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas.
NZ512803A (en) Cyclic guanidine derivatives useful as pesticides
ECSP993005A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos
TH35014A (th) สารฆ่าวัชพืชประเภทเฮทอโรไซคลิค